Grufity logo
Grufity logo

Latest Novo Holdings A/S Stock Portfolio

$1.72Billion | No. of Holdings #25

Novo Holdings A/S Performance

2026 Q2+16.31%
YTD+20.80%
2025+16.51%

About Novo Holdings A/S and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, NOVO HOLDINGS A/S reported an equity portfolio of $1.7 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of NOVO HOLDINGS A/S are EWTX, ASML, . The fund has invested 12.6% of it's portfolio in EDGEWISE THERAPEUTICS INC and 11% of portfolio in ASML HOLDING N V. <br><br> The fund managers got completely rid off APOGEE THERAPEUTICS INC, BIOMARIN PHARMACEUTICAL INC (BMRN) and VALNEVA SE (VALN) stocks. They significantly reduced their stock positions in ARRIVENT BIOPHARMA INC, PHARVARIS N V (PHVS) and MIRUM PHARMACEUTICALS INC (MIRM). NOVO HOLDINGS A/S opened new stock positions in HEMAB THERAPEUTICS HLDGS INC, FLOOR & DECOR HLDGS INC (FND) and DYNE THERAPEUTICS INC (DYN). The fund showed a lot of confidence in some stocks as they added substantially to VIRIDIAN THERAPEUTICS INC (VRDN) and BRIDGEBIO ONCOLOGY THERAPEUT.
Novo Holdings A/S Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$1.72Billion
  as of Aug 14, 2026

Novo Holdings A/S Annual Return Estimates Vs S&P 500

Our best estimate is that NOVO HOLDINGS A/S made a return of 16.31% in the last quarter. In trailing 12 months, it's portfolio return was 54.32%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
hemab therapeutics hldgs inc153,552,000
avalyn pharmaceuticals inc127,838,000
floor & decor hldgs inc47,309,900
alumis inc30,954,000
dyne therapeutics inc21,330,400
insmed inc12,871,500
New stocks bought by Novo Holdings A/S

Additions

Ticker% Inc.
viridian therapeutics inc6.75
bridgebio oncology therapeut2.93
Additions to existing portfolio by Novo Holdings A/S

Reductions

Ticker% Reduced
arrivent biopharma inc-22.77
enliven therapeutics inc-21.88
pharvaris n v-20.00
mirum pharmaceuticals inc-15.09
crinetics pharmaceuticals in-14.84
celldex therapeutics inc new-14.58
4d molecular therapeutics in-11.00
vaxcyte inc-6.98
Novo Holdings A/S reduced stake in above stock

Sold off

Ticker$ Sold
valneva se-6,608,880
biomarin pharmaceutical inc-37,283,400
apogee therapeutics inc-37,876,500
Novo Holdings A/S got rid off the above stocks

Sector Distribution

NOVO HOLDINGS A/S has about 56.7% of it's holdings in Others sector.

  • Others
  • Healthcare
  • Technology
  • Consumer Cyclical
Sector%
Others56.7
Healthcare36.5
Technology4
Consumer Cyclical2.7

Market Cap. Distribution

NOVO HOLDINGS A/S has about 4.3% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MID-CAP
  • LARGE-CAP
  • SMALL-CAP
Category%
UNALLOCATED56.7
MID-CAP36.4
LARGE-CAP4.3
SMALL-CAP2.5

Stocks belong to which Index?

About 38.8% of the stocks held by NOVO HOLDINGS A/S either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
  • S&P 500
Index%
Others61.2
RUSSELL 200035.2
S&P 5003.6
Top 5 Winners (%)%
MQ
marqeta inc
298.0 %
maplight therapeutics inc
76.3 %
ASML
asml holding n v
50.6 %
arrivent biopharma inc
44.8 %
FDMT
4d molecular therapeutics in
40.5 %
Top 5 Winners ($)$
ASML
asml holding n v
63.5 M
maplight therapeutics inc
57.2 M
EWTX
edgewise therapeutics inc
48.8 M
MIRM
mirum pharmaceuticals inc
30.2 M
arrivent biopharma inc
20.1 M
Top 5 Losers (%)%
lanzatech global inc
-57.4 %
BABA
alibaba group hldg ltd
-23.5 %
CRM
salesforce inc
-16.1 %
bridgebio oncology therapeut
-14.7 %
VRDN
viridian therapeutics inc
-5.9 %
Top 5 Losers ($)$
CRM
salesforce inc
-11.8 M
BABA
alibaba group hldg ltd
-7.6 M
bridgebio oncology therapeut
-2.9 M
VRDN
viridian therapeutics inc
-2.5 M
lanzatech global inc
-1.5 M

Novo Holdings A/S Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Novo Holdings A/S

NOVO HOLDINGS A/S has 25 stocks in it's portfolio. About 73.5% of the portfolio is in top 10 stocks. CRM proved to be the most loss making stock for the portfolio. ASML was the most profitable stock for NOVO HOLDINGS A/S last quarter.

$1.72BTotal Value
28.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Novo Holdings A/S, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ASML
Asml Holding N V

Asml Holding N V

ASML
Novo Holdings A/S's holding in Asml Holding N V over time
10.97%94,946
$188.89M
10.97%
unchanged 0 percentunchanged
BABA
Alibaba Group Hldg Ltd

Alibaba Group Hldg Ltd

BABA
Novo Holdings A/S's holding in Alibaba Group Hldg Ltd over time
1.43%257,327
$24.70M
1.43%
unchanged 0 percentunchanged
PHVS
Pharvaris N V

Pharvaris N V

PHVS
Novo Holdings A/S's holding in Pharvaris N V over time
2.81%1,400,000
$48.41M
2.81%
decreased 20 percentreduced
VALN
Valneva Se

Valneva Se

VALN
Novo Holdings A/S's holding in Valneva Se over time
0%0.00
$0.00
0%
decreased 100 percentsold off
Com Shs
Hemab Therapeutics Hldgs Inc

Hemab Therapeutics Hldgs Inc

Novo Holdings A/S's holding in Hemab Therapeutics Hldgs Inc over time
8.92%4,180,550
$153.55M
8.92%
new position
Cl A Ltd Vt Sh
Brookfield Corp

Brookfield Corp

Novo Holdings A/S's holding in Brookfield Corp over time
8.68%3,496,240
$149.53M
8.68%
unchanged 0 percentunchanged